Management Protocol for the Unilateral Posterior Canal - Benign Paroxysmal Positional Vertigo - A Prospective Observational Study.

The objectives of our study were to assess the effectiveness of the single Epley manoeuvre per session for three consecutive days and to determine the protocol for treating posterior canal-Benign Paroxysmal Positional Vertigo (pc-BPPV). At our tertiary care centre, 410 patients with a confirmed diagnosis of unilateral pc-BPPV were included in a prospective observational study. For all the participants, the Epley manoeuvre was performed once daily for three consecutive days.

Correction: Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab.

[This corrects the article DOI: 10.7759/cureus.58941.

Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab.

Hemophilia A (HA) is a genetic disorder of hemostasis associated with a deficiency or reduced activity of clotting factor VIII (FVIII). This disorder remains unacceptably underdiagnosed in India. Early diagnosis and appropriate management of HA can substantially prevent morbidity and mortality.

Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia.

Romiplostim is a Food and Drug Administration (FDA)-approved therapy for immune thrombocytopenia (ITP). Biosimilar is a biological product that has no clinical meaningful difference from an existing FDA-approved reference product. It has a potential of lowering health-care-related cost.

Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia.

[This corrects the article DOI: 10.1007/s12288-022-01602-5.].